|
|
|
|
|
|
|
|
|
Tuesday April 18, 2006
|
|
|
| |
|
8:00 am
|
|
|
9:15 am - 10:00 am
|
|
|
10:15 am - 11:00 am
|
- Private sector initiatives to promote transparency and engage consumers in health care quality
- CMS initiatives to improve transparency of provider quality measures and early results from CMS’ pay-for-performance demonstration
- CMS' early results for innovative payment mechanisms to foster improvements in the quality of care through improved coordination and use of health information technology
- Regional initiatives to disclose provider quality measures and impact on outcomes
Senior Official from CMS - TBA |
| |
Barry M. Straube MD
Acting Director & Chief Clinical Officer, Office of Clinical Standards and Quality
Centers for Medicare and Medicaid Services
 View Biography
|
| |
Marc Volavka
Executive Director
Pennsylvania Health Care Cost Containment Council
View Biography
|
|
|
|
|
11:15 am - 12:00 pm
|
- Policies on certification, data standards, patient privacy and security
- Review of system architectures
- Comparison of funding models
- Physician adoption and incentives to promote adoption
- The role of RHIOs to advance national health IT
|
|
|
|
|
12:00 pm - 1:30 pm
|
|
|
1:30 pm - 2:15 pm
|
- Realigning incentives for all industry sectors to focus on prevention
- Successful public and private sector initiatives to champion prevention programs
- Identifying sustainable business models that support preventive care
- Evaluating net gain to all industry sectors
|
| |
Chris Viehbacher
President
US Pharmaceuticals, GlaxoSmithKline
View Biography
|
|
|
|
|
2:15 pm - 3:30 pm
|
|
|
2:30 pm - 3:30 pm
|
|
|
3:30 pm - 4:15 pm
|
|
|
4:30 pm - 5:15 pm
|
|
|
5:30 pm - 7:00 pm
|
|
Wednesday April 19, 2006
|
|
|
| |
|
7:00 am - 7:45 am
|
|
|
8:00 am - 8:45 am
|
|
|
9:00 am - 10:45 am
|
|
|
11:00 am - 11:45 am
|
- Adoption of evidence-based formularies by 15 Medicaid programs and the private sector including Consumer Reports and AARP
- How Medicare Part D will be pressured to adopt uniform guidelines
- Results from international government bodies reviewing evidence-based research for new drugs that balance costeffectiveness and drug efficacy
|
| Moderator |
|
| |
Mark Gibson
Director, Center for Evidence Based Policy
Oregon Health Sciences
View Biography
|
|
|
| |
David B. Matchar MD, FACP
Professor of Medicine; Director,
Evidence-Based Practice
Center; Center for Clinical
Health Policy Research;
Duke University
View Biography
|
| |
Doug Porter
Assistant Secretary, Health & Recovery Services Administration,
Washington Department of Social & Health Services;
Executive Committee,
National Association of State Medicaid Directors
View Biography
|
|
|
|
12:00 pm - 12:45 pm
|
- Medicaid cost-shifting to employers
- Employer restructuring of retiree benefits
- How subsidization impacts employees’ total compensation
- Review of the Aministration's proposals and feasibility of proposed solutions
- Debate on HSAs and their ability to contain health care spending trend
|
|
|
|
|
12:45 pm - 2:15 pm
|
|
|
2:15 pm - 2:30 pm
|
|
|
2:30 pm - 3:30 pm
|
|
|
3:45 pm - 4:30 pm
|
|
|
|
|
|
|
|
|
|
|